MX2009012482A - Oligonucleotidos de clase a con potencia inmunoestimuladora. - Google Patents
Oligonucleotidos de clase a con potencia inmunoestimuladora.Info
- Publication number
- MX2009012482A MX2009012482A MX2009012482A MX2009012482A MX2009012482A MX 2009012482 A MX2009012482 A MX 2009012482A MX 2009012482 A MX2009012482 A MX 2009012482A MX 2009012482 A MX2009012482 A MX 2009012482A MX 2009012482 A MX2009012482 A MX 2009012482A
- Authority
- MX
- Mexico
- Prior art keywords
- oligonucleotides
- class
- immunostimulatory potency
- immunostimulatory
- potency
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
Abstract
La invención proporciona un ácido nucleico inmunoestimulador que comprende motivos CpG, y procedimientos de usar el mismo para estimular la inmunidad.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US93058007P | 2007-05-17 | 2007-05-17 | |
PCT/IB2008/001199 WO2008142509A2 (en) | 2007-05-17 | 2008-05-15 | Class a oligonucleotides with immunostimulatory potency |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009012482A true MX2009012482A (es) | 2009-12-02 |
Family
ID=39720158
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009012482A MX2009012482A (es) | 2007-05-17 | 2008-05-15 | Oligonucleotidos de clase a con potencia inmunoestimuladora. |
Country Status (15)
Country | Link |
---|---|
US (1) | US20100285041A1 (es) |
EP (1) | EP2160199A2 (es) |
JP (1) | JP2009035530A (es) |
KR (1) | KR20100010509A (es) |
CN (1) | CN101678098A (es) |
AR (1) | AR066626A1 (es) |
AU (1) | AU2008252577A1 (es) |
BR (1) | BRPI0811621A2 (es) |
CA (1) | CA2687441A1 (es) |
IL (1) | IL202096A0 (es) |
MX (1) | MX2009012482A (es) |
RU (1) | RU2009142211A (es) |
TW (1) | TW200916115A (es) |
WO (1) | WO2008142509A2 (es) |
ZA (1) | ZA200908062B (es) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030026782A1 (en) * | 1995-02-07 | 2003-02-06 | Arthur M. Krieg | Immunomodulatory oligonucleotides |
US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
US6406705B1 (en) | 1997-03-10 | 2002-06-18 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
US7276489B2 (en) * | 2002-10-24 | 2007-10-02 | Idera Pharmaceuticals, Inc. | Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends |
US8153141B2 (en) | 2002-04-04 | 2012-04-10 | Coley Pharmaceutical Gmbh | Immunostimulatory G, U-containing oligoribonucleotides |
US20040053880A1 (en) | 2002-07-03 | 2004-03-18 | Coley Pharmaceutical Group, Inc. | Nucleic acid compositions for stimulating immune responses |
AR040996A1 (es) | 2002-08-19 | 2005-04-27 | Coley Pharm Group Inc | Acidos nucleicos inmunoestimuladores |
US7998492B2 (en) | 2002-10-29 | 2011-08-16 | Coley Pharmaceutical Group, Inc. | Methods and products related to treatment and prevention of hepatitis C virus infection |
NZ546475A (en) | 2003-10-30 | 2008-08-29 | Coley Pharm Gmbh | C-Class oligonucleotide analogs with enhanced immunostimulatory potency |
PT2078080E (pt) | 2006-09-27 | 2015-09-18 | Coley Pharm Gmbh | Análogos dos oligonucleotídeos cpg que contêm análogos t hidrofóbicos com atividade imunoestimulante potenciada |
EP2575878B1 (en) * | 2010-05-28 | 2018-06-13 | Zoetis Belgium S.A. | Vaccines comprising cholesterol and cpg as sole adjuvant-carrier molecules |
EP2471926A3 (en) * | 2010-12-30 | 2012-07-11 | Intervet International BV | Immunostimulatory oligodeoxynucleotides |
EP3238727B1 (en) * | 2014-12-25 | 2023-01-18 | National Institutes of Biomedical Innovation, Health and Nutrition | Non-aggregating immunostimulatory oligonucleotides |
JP6698069B2 (ja) * | 2015-03-20 | 2020-05-27 | 国立研究開発法人医薬基盤・健康・栄養研究所 | 免疫賦活活性を有するCpGスペーサーオリゴヌクレオチド含有複合体及びその用途 |
WO2019240503A1 (ko) * | 2018-06-12 | 2019-12-19 | 주식회사 에이엠사이언스 | B형 간염 예방 또는 치료용 조성물 |
WO2019240504A1 (en) * | 2018-06-12 | 2019-12-19 | Am Sciences Co., Ltd. | Modified oligonucleotides for inhibition of target gene expression |
WO2023034853A2 (en) * | 2021-08-31 | 2023-03-09 | City Of Hope | Oligonucleotides having 6-thio-2'-deoxyguanosine residues and uses thereof |
CN113517062B (zh) * | 2021-09-14 | 2021-12-10 | 青岛未来移动医疗科技有限公司 | 一种智能疫苗雾化系统及使用方法 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3854480A (en) * | 1969-04-01 | 1974-12-17 | Alza Corp | Drug-delivery system |
US4469863A (en) * | 1980-11-12 | 1984-09-04 | Ts O Paul O P | Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof |
US4675189A (en) * | 1980-11-18 | 1987-06-23 | Syntex (U.S.A.) Inc. | Microencapsulation of water soluble active polypeptides |
US5023243A (en) * | 1981-10-23 | 1991-06-11 | Molecular Biosystems, Inc. | Oligonucleotide therapeutic agent and method of making same |
US4452775A (en) * | 1982-12-03 | 1984-06-05 | Syntex (U.S.A.) Inc. | Cholesterol matrix delivery system for sustained release of macromolecules |
US5075109A (en) * | 1986-10-24 | 1991-12-24 | Southern Research Institute | Method of potentiating an immune response |
US5133974A (en) * | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
DE4321946A1 (de) * | 1993-07-01 | 1995-01-12 | Hoechst Ag | Methylphosphonsäureester, Verfahren zu deren Herstellung und deren Verwendung |
US5658738A (en) * | 1994-05-31 | 1997-08-19 | Becton Dickinson And Company | Bi-directional oligonucleotides that bind thrombin |
US6207646B1 (en) * | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
US6194388B1 (en) | 1994-07-15 | 2001-02-27 | The University Of Iowa Research Foundation | Immunomodulatory oligonucleotides |
US6239116B1 (en) | 1994-07-15 | 2001-05-29 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
US5736152A (en) * | 1995-10-27 | 1998-04-07 | Atrix Laboratories, Inc. | Non-polymeric sustained release delivery system |
WO1998037919A1 (en) * | 1997-02-28 | 1998-09-03 | University Of Iowa Research Foundation | USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE IN THE TREATMENT OF LPS-ASSOCIATED DISORDERS |
WO1998052581A1 (en) * | 1997-05-20 | 1998-11-26 | Ottawa Civic Hospital Loeb Research Institute | Vectors and methods for immunization or therapeutic protocols |
US6218371B1 (en) * | 1998-04-03 | 2001-04-17 | University Of Iowa Research Foundation | Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines |
EP2322210A1 (en) * | 1999-04-19 | 2011-05-18 | GlaxoSmithKline Biologicals S.A. | Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
US6949520B1 (en) * | 1999-09-27 | 2005-09-27 | Coley Pharmaceutical Group, Inc. | Methods related to immunostimulatory nucleic acid-induced interferon |
NZ517928A (en) * | 1999-09-27 | 2004-09-24 | Coley Pharm Gmbh | Methods related to immunostimulatory nucleic acid-induced interferon |
SI1446162T1 (sl) | 2001-08-17 | 2009-04-30 | Coley Pharm Gmbh | Kombinacija zaporedja imunostimulatornih oligonukleotidov z izboljšano aktivnostjo |
US20080009455A9 (en) * | 2005-02-24 | 2008-01-10 | Coley Pharmaceutical Group, Inc. | Immunostimulatory oligonucleotides |
MX2007012488A (es) * | 2005-04-08 | 2008-03-11 | Coley Pharm Group Inc | Metodos para el tratamiento de asma exacerbado por enfermedad infecciosa. |
-
2008
- 2008-05-15 AU AU2008252577A patent/AU2008252577A1/en not_active Abandoned
- 2008-05-15 CN CN200880016477A patent/CN101678098A/zh active Pending
- 2008-05-15 US US12/600,364 patent/US20100285041A1/en not_active Abandoned
- 2008-05-15 EP EP08750940A patent/EP2160199A2/en not_active Withdrawn
- 2008-05-15 WO PCT/IB2008/001199 patent/WO2008142509A2/en active Application Filing
- 2008-05-15 BR BRPI0811621-0A2A patent/BRPI0811621A2/pt not_active IP Right Cessation
- 2008-05-15 KR KR1020097026396A patent/KR20100010509A/ko not_active Application Discontinuation
- 2008-05-15 RU RU2009142211/15A patent/RU2009142211A/ru not_active Application Discontinuation
- 2008-05-15 MX MX2009012482A patent/MX2009012482A/es unknown
- 2008-05-15 CA CA002687441A patent/CA2687441A1/en not_active Abandoned
- 2008-05-16 JP JP2008129762A patent/JP2009035530A/ja active Pending
- 2008-05-16 AR ARP080102108A patent/AR066626A1/es unknown
- 2008-05-16 TW TW097118306A patent/TW200916115A/zh unknown
-
2009
- 2009-11-12 IL IL202096A patent/IL202096A0/en unknown
- 2009-11-16 ZA ZA200908062A patent/ZA200908062B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CA2687441A1 (en) | 2008-11-27 |
CN101678098A (zh) | 2010-03-24 |
WO2008142509A2 (en) | 2008-11-27 |
IL202096A0 (en) | 2010-06-16 |
JP2009035530A (ja) | 2009-02-19 |
RU2009142211A (ru) | 2011-05-27 |
US20100285041A1 (en) | 2010-11-11 |
KR20100010509A (ko) | 2010-02-01 |
EP2160199A2 (en) | 2010-03-10 |
TW200916115A (en) | 2009-04-16 |
ZA200908062B (en) | 2010-06-30 |
WO2008142509A3 (en) | 2009-03-05 |
BRPI0811621A2 (pt) | 2014-10-21 |
AR066626A1 (es) | 2009-09-02 |
AU2008252577A1 (en) | 2008-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009012482A (es) | Oligonucleotidos de clase a con potencia inmunoestimuladora. | |
CA121621S (en) | Bottle | |
BRPI0417823A (pt) | métodos para uso de bifidobactérias probióticas para animais de estimação | |
MX2008001652A (es) | Copolimeros de poliamonio-polisiloxano. | |
MY165643A (en) | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions | |
ZA200709516B (en) | C. perfringens alpha toxoid vaccine | |
EP2079500A4 (en) | DEVICES AND METHODS FOR INFUSION | |
MY178288A (en) | Complex containing oligonucleotide having immunopotentiating activity and use thereof | |
PL2034015T3 (pl) | Immunostymulujący oligonukleotyd i jego zastosowanie farmaceutyczne | |
WO2004005476A3 (en) | Nucleic acid compositions for stimulating immune responses | |
PT2179039T (pt) | Motivos de sequência de arn no contexto de ligações de internucleótidos precisas que induzem perfis modulatórios imunitários específicos | |
MX2009004866A (es) | Vacuna para enfermedad de lyme canina. | |
GB2444676A (en) | Adjuvanted vaccine | |
CA122274S (en) | Hanger clip | |
PL1713438T3 (pl) | Mydło lecznicze | |
CA121620S (en) | Bottle | |
CA125780S (en) | Air freshener device | |
RU2008125409A (ru) | Ген hgfopt фактора роста гепатоцитов | |
AU306758S (en) | Console | |
AU305008S (en) | Shelving | |
AU306757S (en) | Buffet | |
AU305696S (en) | Bookcase | |
AU302484S (en) | Entertainment unit | |
AU302487S (en) | Entertainment unit | |
AU300904S (en) | Entertainment unit |